Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines ›Pfizer Europe MA EEIG
Medicines register · Ireland

Pfizer Europe MA EEIG — licensed medicines

141 medicines held by Pfizer Europe MA EEIG on the Irish market, from the HPRA register.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
141 of 10,336 medicines
Download
Medicine
Active substance
Licence holder
Status
Somavert 25 mg powder and solvent for solution for injection EU/1/02/240/009-010
Pegvisomant
Pfizer Europe MA EEIG
—
Somavert 30 mg powder and solvent for solution for injection EU/1/02/240/011-012
Pegvisomant
Pfizer Europe MA EEIG
—
Sutent 12.5 mg hard capsules EU/1/06/347/001
Sunitinib malate
Pfizer Europe MA EEIG
—
Sutent 25 mg hard capsules EU/1/06/347/002
Sunitinib malate
Pfizer Europe MA EEIG
—
Sutent 37.5 mg hard capsules EU/1/06/347/7-8
Sunitinib malate
Pfizer Europe MA EEIG
—
Sutent 50 mg hard capsules EU/1/06/347/003
Sunitinib malate
Pfizer Europe MA EEIG
—
Talzenna 0.1 mg Capsule, hard EU/1/19/1377/007
TALAZOPARIB TOSYLATE
Pfizer Europe MA EEIG
—
Talzenna 0.25 mg Capsule, hard EU/1/19/1377/001-004
TALAZOPARIB TOSYLATE
Pfizer Europe MA EEIG
—
Talzenna 0.5 mg hard capsules EU/1/19/1377/009
Talazoparib tosilate
Pfizer Europe MA EEIG
—
Talzenna 1 mg Capsule, hard EU/1/19/1377/005-006
TALAZOPARIB TOSYLATE
Pfizer Europe MA EEIG
—
Topotecan Hospira 4 mg/4 ml concentrate for solution for infusion EU/1/10/633/001-2
Topotecan (as hydrochloride)
Pfizer Europe MA EEIG
—
Torisel 30 mg concentrate and solvent for solution for infusion EU/1/07/424/001
Temsirolimus
Pfizer Europe MA EEIG
—
TOVIAZ 4 mg prolonged-release tablets EU/1/07/386/1-5
Fesoterodine fumarate
Pfizer Europe MA EEIG
—
TOVIAZ 8 mg prolonged-release tablets EU/1/07/386/6-10
Fesoterodine fumarate
Pfizer Europe MA EEIG
—
Trazimera 150 mg powder for concentrate for solution for infusion EU/1/18/1295/001
Trastuzumab
Pfizer Europe MA EEIG
—
Trumenba suspension for injection in pre-filled syringe. Meningococcal group B vaccine (recombinant, adsorbed). EU/1/17/1187/001-006
Neisseria meningitidis serogroup b recombinant lipoprotein (rlp2086; sub family a), Neisseria meningitidis serogroup b recombinant lipoprotein (rlp2086; sub family b)
Pfizer Europe MA EEIG
—
TUKYSA 150 mg film-coated tablets EU/1/20/1526/002
Tucatinib
Pfizer Europe MA EEIG
—
TUKYSA 50 mg film-coated tablets EU/1/20/1526/001
Tucatinib
Pfizer Europe MA EEIG
—
Tygacil 50 mg powder for solution for infusion EU/1/06/336/01
Tigecycline
Pfizer Europe MA EEIG
—
Velsipity 2 mg film-coated tablets EU/1/23/1790/001-003
Etrasimod arginine
Pfizer Europe MA EEIG
—
VFEND 200 mg film-coated tablets EU/1/02/212/013-021
Voriconazole
Pfizer Europe MA EEIG
—
Vfend 200 mg powder for solution for infusion EU/1/02/212/025
Voriconazole
Pfizer Europe MA EEIG
—
Vfend 40 mg/ml powder for oral suspension EU/1/02/212/026
Voriconazole
Pfizer Europe MA EEIG
—
VFEND 50 mg film-coated tablets EU/1/02/212/001-009
Voriconazole
Pfizer Europe MA EEIG
—
Vizimpro 15 mg Film-coated tablet EU/1/19/1354/001
DACOMITINIB MONOHYDRATE
Pfizer Europe MA EEIG
—
Vizimpro 30 mg Film-coated tablet EU/1/19/1354/002
DACOMITINIB MONOHYDRATE
Pfizer Europe MA EEIG
—
Vizimpro 45 mg Film-coated tablet EU/1/19/1354/003
DACOMITINIB MONOHYDRATE
Pfizer Europe MA EEIG
—
Vydura 75 mg oral lyophilisate EU/1/22/1645/001-003
Rimegepant sulfate
Pfizer Europe MA EEIG
—
Vyndaqel 61 mg soft capsules EU/1/11/717/001
Tafamidis
Pfizer Europe MA EEIG
—
Vyndaqel 61 mg soft capsules EU/1/11/717/003-004
Tafamidis
Pfizer Europe MA EEIG
—
XALKORI 20 mg granules in capsules for opening EU/1/12/793/005
Crizotinib
Pfizer Europe MA EEIG
—
XALKORI 200 mg hard capsules EU/1/12/793/001-002
Crizotinib
Pfizer Europe MA EEIG
—
XALKORI 250 mg hard capsules EU/1/12/793/003-004
Crizotinib
Pfizer Europe MA EEIG
—
XELJANZ 1 mg/mL oral solution EU/1/17/1178/015
TOFACITINIB
Pfizer Europe MA EEIG
—
XELJANZ 10 mg film-coated tablets EU/1/17/1178/005-009
Tofacitinib citrate
Pfizer Europe MA EEIG
—
XELJANZ 11 mg film-coated tablets EU/1/17/1178/010-013
TOFACITINIB
Pfizer Europe MA EEIG
—
XELJANZ 5 mg film-coated tablets EU/1/17/1178/001-003
Tofacitinib citrate
Pfizer Europe MA EEIG
—
Zirabev 25 mg/ml concentrate for solution for infusion EU/1/18/1344/001-002
Bevacizumab
Pfizer Europe MA EEIG
—
Zoledronic Acid Hospira 4 mg/100 ml solution for infusion EU/1/12/800/003
Zoledronic acid monohydrate
Pfizer Europe MA EEIG
—
Zoledronic Acid Hospira 4 mg/5 ml concentrate for solution for infusion EU/1/12/800/001-002
Zoledronic acid monohydrate
Pfizer Europe MA EEIG
—
Zoledronic Acid Hospira 5 mg/100 ml solution for infusion EU/1/12/800/004
Zoledronic acid monohydrate
Pfizer Europe MA EEIG
—
Showing 101–141 of 141
Previous 1 2 3
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 4 October 2026. https://priyalifescience.com/medicines/company/pfizer-europe-ma-eeig

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.